CD39 Identifies Tumor-Reactive CD8 T cells in Patients With Lung Cancer is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2022). On theSindex it has a DataRank of 0.240. It has been cited 3 times, with 2 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0.0324
From 2 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 2 citers.
National Institutes of Health
Grant: 5T32CA009207-43
Investigational Cancer Therapeutics Training Program
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 5R01CA056821-19
Immunization Against Melanoma Differentiation Antigens
National Institutes of Health
Grant: 5U24CA213274-02
Coordinating center for the NCI small cell lung cancer research consortium
National Institutes of Health
Grant: 5K08CA248723-03
Assessment of Tim-4+ Pleural Macrophages as Negative Regulators of Anti-Tumor T Cell Immunity in Lung Cancer
National Institutes of Health
Grant: 5R37CA259177-04
Molecular mechanisms of T cell responses to a clonal neoantigen resulting from a mutated driver oncogene.
National Institutes of Health
Grant: 5R01CA197936-02
Determinants of acquired resistance in small cell lung cancer
National Institutes of Health
Grant: 5P01CA129243-07
Mechanisms and Modulators of Sensitivity and Resistance to EGFR Inhibitors in Lu
Fields of Study
Keywords
Sustainable Development Goals